The effect of ferulic acid ethyl ester on leptin-induced proliferation and migration of aortic smooth muscle cells.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4558489)

Published in Exp Mol Med on August 28, 2015

Authors

Yung-Chieh Tsai1,2,3, Yen-Mei Lee4, Chih-Hsiung Hsu5, Sy-Ying Leu6, Hsiao-Yen Chiang7, Mao-Hsiung Yen4, Pao-Yun Cheng8

Author Affiliations

1: Department of Obstetrics and Gynecology, Chi-Mei Medical Center, Tainan, Taiwan.
2: Department of Medicine, Taipei Medical University, Taipei, Taiwan.
3: Department of Sport Management, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
4: Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan.
5: Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
6: Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
7: Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan.
8: Department of Physiology and Biophysics; Graduate Institute of Physiology, National Defense Medical Center, Taipei, Taiwan.

Articles cited by this

Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28

CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (1999) 20.34

Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 18.31

Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med (1996) 16.98

Leptin and the regulation of body weight in mammals. Nature (1998) 14.84

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A (1999) 10.75

Adipose tissue, inflammation, and cardiovascular disease. Circ Res (2005) 8.72

New functional activities for the p21 family of CDK inhibitors. Genes Dev (1997) 6.97

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J (1999) 5.44

beta-catenin signaling and cancer. Bioessays (1999) 4.16

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation (2001) 3.57

Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol (2003) 3.15

Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1). Circulation (2000) 2.14

Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol (2003) 2.01

Leptin and atherosclerosis. Atherosclerosis (2006) 1.95

A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res (2002) 1.72

Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol (2004) 1.64

Antioxidant properties of ferulic acid and its related compounds. J Agric Food Chem (2002) 1.45

TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res (2008) 1.40

Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem (2005) 1.37

Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem (2002) 1.35

GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood (2006) 1.34

p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem (2000) 1.28

Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol (2001) 1.25

Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res (2003) 1.23

Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes (2005) 1.21

Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Eur J Clin Invest (2006) 1.20

Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem (2003) 1.17

Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci (2001) 1.15

Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res (2003) 1.12

Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. J Biomed Sci (2005) 1.10

Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol (2006) 1.08

Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases. Acta Pharmacol Sin (2004) 1.08

Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signaling pathway. J Cell Biochem (2008) 1.07

Growth factors and mitogen-activated protein kinases. Hypertension (1998) 1.07

Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal (2004) 1.02

Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord (2000) 0.98

In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders. Neurochem Int (2005) 0.98

Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells (review). Int J Mol Med (1998) 0.97

Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience (2010) 0.96

Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kappaB. Acta Biochim Biophys Sin (Shanghai) (2010) 0.95

Redox regulation of cellular stress response by ferulic acid ethyl ester in human dermal fibroblasts: role of vitagenes. Clin Dermatol (2008) 0.93

Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II. Eur J Pharmacol (2004) 0.93

In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J Neurosci Res (2006) 0.92

Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proc Natl Acad Sci U S A (2008) 0.90

Obesity and cardiovascular risk. Growth Horm IGF Res (2003) 0.90

D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells. Mol Cell Endocrinol (2013) 0.89

Cell proliferation induced by reactive oxygen species is mediated via mitogen-activated protein kinase in Chinese hamster lung fibroblast (V79) cells. Mol Cells (2003) 0.88

The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis. Br J Pharmacol (2013) 0.88

Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells. Am J Transplant (2004) 0.87

Protective effect of ferulic acid ethyl ester against oxidative stress mediated by UVB irradiation in human epidermal melanocytes. Free Radic Res (2009) 0.86

Antianginal effects of lercanidipine on the vasopressin or methacholine induced anginal model in rats. Biol Pharm Bull (2005) 0.79